ангиотензин转化酶2和肝脏SARS-CoV-2感染:调控,关联和治疗影响
Yu-Wei Luo1, Ai-Long Huang1, Kai-Fu Tang2
1Key Laboratory of Molecular Biology on Infectious Disease, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
World journal of gastroenterology
|February 17, 2025
概括
血管激素转化酶2 (ACE2) 受体在肝脏SARS-CoV-2感染中起着关键作用. 慢性肝病患者中ACE2表达升高与COVID-19感染增加和肝损伤严重程度相关.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 利用血管素转化酶2 (ACE2) 受体进入宿主细胞.
- 在2019年冠状病毒病 (COVID-19) 患者中观察到肝脏SARS-CoV-2感染和相关的肝损伤.
研究的目的:
- 阐明ACE2在肝脏SARS-CoV-2感染中的作用.
- 了解COVID-19相关肝脏病理背后的机制.
- 为了确定COVID-19的潜在治疗点.
主要方法:
- 对肝脏ACE2表达和SARS-CoV-2感染现有研究的综述.
- 对链接慢性肝病,ACE2和COVID-19严重程度的数据的分析.
主要成果:
- 肝脏ACE2表达在患有先前存在的慢性肝病的患者中升高.
- 在这些患者中,肝脏SARS-CoV-2感染的频率更高.
- 在COVID-19患者中,肝损伤的严重程度与肝脏ACE2的升高有关.
结论:
- 肝脏ACE2在肝脏SARS-CoV-2感染的发病过程中具有重要意义.
- 向肝脏ACE2可能是缓解COVID-19相关肝损伤的治疗策略,特别是在患有慢性肝病的个体中.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
457
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
457
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
573
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
573
Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


